2026-08-11Bullish
+20.45%weekly changeShares surged after Charles River reported strong Q2 2026 earnings, returned to organic revenue growth, and raised full-year guidance.
read the report →← every name covered
S&P 500
CRL
Charles River Laboratories International, Inc.
latest move
+20.45%
2026-08-11
5 sessions · 2026-06-29 → 2026-08-11 · avg 19.51% · largest 24.24%
Charles River is an early-stage contract research organization that provides animal research models, drug discovery services, safety assessment, and biological manufacturing support.
Price history
stitched from the price window carried by each report
Every session it moved
newest first2026-08-10Bullish
+19.98%weekly changeCRL surged following strong Q2 2026 earnings, a return to positive organic revenue growth, raised full-year guidance, and analyst upgrades.
read the report →2026-08-05Bullish
+11.36%24 hours changeCRL stock surged following a strong Q2 2026 earnings beat and an across-the-board upward revision to full-year 2026 financial guidance.
read the report →2026-06-30Bullish
+21.54%weekly changeThe stock surged following a Morgan Stanley upgrade and the announcement of a strategic AI drug discovery partnership with Eli Lilly.
read the report →2026-06-29Bullish
+24.24%weekly changeMorgan Stanley upgraded CRL to Overweight on signs that recovering biopharma funding is translating into increased R&D bookings.
read the report →